FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1217590001: Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
5036802013 Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
5036803015 Cefalexin 250 mg tablet for oral suspension en Synonym Active Entire term case insensitive SNOMED CT core module
5036804014 Cephalexin 250 mg tablet for oral suspension en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Is a Product containing only cefalexin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient Cefalexin true Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance Cefalexin true Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start